Company’s 36-month beta value is 1.45.Analysts have differing opinions on the stock, with 8 analysts rating it as a “buy,” 1 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for ALHC is 92.15M, and currently, short sellers hold a 10.15% ratio of that floaft. The average trading volume of ALHC on January 01, 2025 was 1.87M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ALHC) stock’s latest price update
Alignment Healthcare Inc (NASDAQ: ALHC) has experienced a rise in its stock price by 0.81 compared to its previous closing price of 11.16. However, the company has seen a gain of 5.04% in its stock price over the last five trading days. globenewswire.com reported 2024-12-30 that ORANGE, Calif., Dec. 30, 2024 (GLOBE NEWSWIRE) — Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 15, at 11:15 a.m. PST.
ALHC’s Market Performance
ALHC’s stock has risen by 5.04% in the past week, with a monthly drop of -10.79% and a quarterly rise of 12.50%. The volatility ratio for the week is 4.98% while the volatility levels for the last 30 days are 5.03% for Alignment Healthcare Inc The simple moving average for the last 20 days is -0.08% for ALHC’s stock, with a simple moving average of 24.47% for the last 200 days.
Analysts’ Opinion of ALHC
Many brokerage firms have already submitted their reports for ALHC stocks, with Stephens repeating the rating for ALHC by listing it as a “Overweight.” The predicted price for ALHC in the upcoming period, according to Stephens is $17 based on the research report published on December 03, 2024 of the previous year 2024.
BofA Securities gave a rating of “Buy” to ALHC, setting the target price at $11 in the report published on May 30th of the previous year.
ALHC Trading at -5.00% from the 50-Day Moving Average
After a stumble in the market that brought ALHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.05% of loss for the given period.
Volatility was left at 5.03%, however, over the last 30 days, the volatility rate increased by 4.98%, as shares sank -12.38% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +3.40% upper at present.
During the last 5 trading sessions, ALHC rose by +5.04%, which changed the moving average for the period of 200-days by +125.45% in comparison to the 20-day moving average, which settled at $11.26. In addition, Alignment Healthcare Inc saw 30.66% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALHC starting from Maroney Dawn Christine, who sale 30,000 shares at the price of $11.33 back on Dec 16 ’24. After this action, Maroney Dawn Christine now owns 1,636,097 shares of Alignment Healthcare Inc, valued at $340,008 using the latest closing price.
DAWN CHRISTINE MARONEY, the Officer of Alignment Healthcare Inc, proposed sale 90,000 shares at $11.45 during a trade that took place back on Dec 16 ’24, which means that DAWN CHRISTINE MARONEY is holding shares at $1,030,500 based on the most recent closing price.
Stock Fundamentals for ALHC
Current profitability levels for the company are sitting at:
- -0.05 for the present operating margin
- 0.1 for the gross margin
The net margin for Alignment Healthcare Inc stands at -0.06. The total capital return value is set at -0.36. Equity return is now at value -95.13, with -19.71 for asset returns.
Based on Alignment Healthcare Inc (ALHC), the company’s capital structure generated 0.65 points at debt to capital in total, while cash flow to debt ratio is standing at -0.68. The debt to equity ratio resting at 1.85. The interest coverage ratio of the stock is -5.14.
Currently, EBITDA for the company is -105.3 million with net debt to EBITDA at 1.27. When we switch over and look at the enterprise to sales, we see a ratio of 0.83. The receivables turnover for the company is 17.77for trailing twelve months and the total asset turnover is 3.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.60.
Conclusion
In a nutshell, Alignment Healthcare Inc (ALHC) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
